Blog

Researchers running HGH or secretagogue protocols frequently have no feedback loop. They’re dosing on schedule and observing subjective outcomes — sleep quality, body composition over time, recovery — without any objective measure of whether the protocol is producing the expected physiological response. IGF-1 bloodwork closes that loop. It is the single most reliable proxy marker…

Third-party purity verification at the point of manufacture is necessary. It is not sufficient.

Most recomposition research in the literature studies peptides in isolation. That’s useful for establishing mechanism, but it misses what observational researchers are increasingly documenting: GLP-1 class peptides and growth hormone secretagogues appear to work through complementary, non-overlapping pathways that address both sides of the recomposition equation simultaneously.

The Retatrutide clinical trial generated impressive headlines. But headline-optimized protocols and researcher-optimized protocols are two different things. If you’re running a Reta research protocol and following the trial’s injection schedule, you may be creating problems the trial never bothered to solve.